Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
About this item
Full title
Author / Creator
Sacco, Joseph J , Carvajal, Richard D , Butler, Marcus O , Shoushtari, Alexander N , Hassel, Jessica C , Ikeguchi, Alexandra , Hernandez-Aya, Leonel , Nathan, Paul , Hamid, Omid , Piulats, Josep M , Rioth, Matthew , Johnson, Douglas B , Luke, Jason J , Espinosa, Enrique , Leyvraz, Serge , Collins, Laura , Holland, Chris and Sato, Takami
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundTebentafusp, a bispecific (gp100×CD3) ImmTAC, significantly improved overall survival (OS) outcomes for HLA-A*02:01+ adult patients with untreated metastatic uveal melanoma (mUM) and showed promising survival in previously treated mUM with 1-year OS of 62% in the primary analysis of study IMCgp100-102. Here we report long-term outcomes fr...
Alternative Titles
Full title
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
Authors, Artists and Contributors
Author / Creator
Carvajal, Richard D
Butler, Marcus O
Shoushtari, Alexander N
Hassel, Jessica C
Ikeguchi, Alexandra
Hernandez-Aya, Leonel
Nathan, Paul
Hamid, Omid
Piulats, Josep M
Rioth, Matthew
Johnson, Douglas B
Luke, Jason J
Espinosa, Enrique
Leyvraz, Serge
Collins, Laura
Holland, Chris
Sato, Takami
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b89b2a51187f4158bed6c6e774c8ce00
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b89b2a51187f4158bed6c6e774c8ce00
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2024-009028
